V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20202605 | 20153464 | 1.72 | 50.4 | Curative (C) | 2017-10-02 | 2018-02-17 | Trastuzumab | 02 | N | TRASTUZUMAB | 100215306 |
| 20202613 | 20153465 | 1.65 | null | Curative (C) | 2020-04-07 | 2020-05-19 | Trastuzumab | 02 | N | TRASTUZUMAB | 101215453 |
| 20202626 | 20153466 | 1.95 | 56 | Curative (C) | null | 2017-12-10 | CETUXIMAB | Y | Y | CAPECITABINE + CISPLATIN | 101346855 |
| 20202633 | 20153467 | 1.56 | 50 | Adjuvant (A) | 2017-04-25 | 2017-04-29 | Cetuximab 14 day | N | N | CETUXIMAB | 100988161 |
| 20202636 | 20153468 | 1.8 | 85.7 | null | 2019-09-23 | 2019-10-16 | Trastuzumab | 02 | null | TRASTUZUMAB | 101405354 |
| 20202639 | 20153469 | 1.49 | 62.5 | Adjuvant (A) | 2019-10-01 | 2019-12-21 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100449093 |
| 20202645 | 20153470 | 1.58 | 83 | Palliative (P) | 2018-12-24 | 2019-01-05 | CETUXIMAB | null | N | CETUXIMAB | 101757259 |
| 20202647 | 20153471 | 1.75 | 87.2 | Curative (C) | 2017-11-30 | 2017-12-07 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101410878 |
| 20202661 | 20153472 | 1.75 | 57 | null | 2018-10-12 | 2018-10-12 | Trastuzumab | 02 | N | TRASTUZUMAB | 100950247 |
| 20202685 | 20153473 | 1.56 | 116.4 | Neo-adjuvant (N) | 2022-01-26 | 2022-02-21 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101165156 |
| 20202701 | 20153474 | 1.65 | 91 | 03 | 2019-07-28 | 2019-10-15 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101494517 |
| 20202704 | 20153475 | 1.77 | 71.6 | null | 2016-03-17 | 2016-07-25 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100843821 |
| 20202723 | 20153476 | 1.8 | 73.4 | null | 2019-04-20 | 2019-04-27 | CETUXIMAB | 02 | N | CETUXIMAB | 100254220 |
| 20202725 | 20153477 | 1.66 | 127 | Palliative (P) | 2017-10-12 | 2017-10-23 | CETUXIMAB | 02 | Y | CETUXIMAB | 100398858 |
| 20202733 | 20153478 | 1.74 | 54 | Palliative (P) | 2019-02-01 | 2019-04-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100075930 |
| 20202747 | 20153479 | 1.65 | null | null | 2018-12-26 | 2019-01-02 | CETUXIMAB | 2 | null | TRASTUZUMAB | 101044291 |
| 20202761 | 20153480 | 1.66 | 85 | Palliative (P) | 2017-04-23 | 2017-05-21 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101095291 |
| 20202766 | 20153481 | 1.65 | 48.5 | null | 2016-06-18 | 2016-06-18 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101449440 |
| 20202775 | 20153482 | 1.61 | 91.4 | Palliative (P) | 2016-08-03 | 2017-06-24 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100634463 |
| 20202783 | 20153483 | 1.64 | 82.4 | Palliative (P) | 2016-08-29 | 2016-09-06 | Trastuzumab Subcutaneous | 99 | N | TRASTUZUMAB | 101557139 |
| 20202784 | 20153484 | 1.55 | 53.6 | null | 2017-09-14 | 2017-10-07 | Capecitabine + Cisplatin | null | null | CAPECITABINE + CISPLATIN | 100215588 |
| 20202789 | 20153485 | 1.7 | 75 | Palliative (P) | 2018-05-07 | 2018-06-06 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100228406 |
| 20202800 | 20153486 | 1.63 | 101.2 | Palliative (P) | 2021-09-30 | 2021-11-09 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100905041 |
| 20202810 | 20153487 | 1.56 | 73.8 | Palliative (P) | 2019-03-09 | 2019-03-21 | CETUXIMAB | 02 | N | CETUXIMAB | 101349493 |
| 20202812 | 20153488 | 1.81 | 96.2 | Neo-adjuvant (N) | 2019-09-05 | 2019-10-01 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100134408 |
| 20202847 | 20153489 | 1.74 | 58.5 | Palliative (P) | 2020-02-07 | 2020-02-18 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101635771 |
| 20202851 | 20153490 | 1.65 | 77.3 | Palliative (P) | 2021-02-07 | 2021-02-28 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100576991 |
| 20202854 | 20153491 | 1.7 | 65 | Neo-adjuvant (N) | 2017-12-07 | 2017-12-19 | CETUXIMAB | 02 | N | CETUXIMAB | 101768514 |
| 20202862 | 20153492 | 1.77 | 75 | Palliative (P) | 2017-07-25 | 2017-07-27 | CETUXIMAB | 02 | N | CETUXIMAB | 101645386 |
| 20202865 | 20153493 | 1.62 | 90.1 | Neo-adjuvant (N) | 2016-10-25 | 2016-11-05 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100353527 |
| 20202869 | 20153494 | 1.73 | 75.3 | 03 | 2019-04-02 | 2020-04-09 | Trastuzumab 21 day maintenance | N | N | TRASTUZUMAB | 101203409 |
| 20202874 | 20153495 | 1.91 | 93.4 | Palliative (P) | 2019-11-08 | 2019-11-29 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101752602 |
| 20202883 | 20153496 | 1.7 | 46.6 | 03 | 2019-03-27 | 2019-03-27 | CETUXIMAB | 02 | Y | CETUXIMAB | 100114815 |
| 20202897 | 20153497 | 1.73 | 133 | null | 2017-11-06 | 2017-11-17 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100519243 |
| 20202900 | 20153498 | 1.89 | 87.6 | Neo-adjuvant (N) | 2020-06-20 | 2020-06-22 | Trastuzumab | 02 | null | TRASTUZUMAB | 101198219 |
| 20202902 | 20153499 | 1.72 | 66.6 | Curative (C) | 2021-10-26 | 2021-11-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 100872284 |
| 20202904 | 20153500 | 1.56 | 63.2 | null | 2017-09-23 | 2017-10-02 | Cetuximab 14 day | 02 | null | TRASTUZUMAB | 100393953 |
| 20202920 | 20153501 | 1.72 | 71.4 | Curative (C) | 2019-10-27 | 2019-12-03 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101156331 |
| 20202939 | 20153502 | 1.65 | 82.2 | Adjuvant (A) | 2020-10-21 | 2020-10-25 | Trastuzumab | 02 | N | TRASTUZUMAB | 101425264 |
| 20202940 | 20153503 | 1.63 | 83 | Palliative (P) | 2018-07-26 | 2018-08-02 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100175482 |
| 20202965 | 20153504 | 1.71 | 50 | Palliative (P) | 2020-08-27 | 2021-07-18 | CETUXIMAB | N | N | CETUXIMAB | 101466978 |
| 20202966 | 20153505 | 1.82 | 73.8 | Palliative (P) | 2018-05-03 | 2018-06-18 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101683154 |
| 20203003 | 20153506 | 1.76 | null | Palliative (P) | 2019-09-05 | 2020-09-16 | Trastuzumab | 02 | N | TRASTUZUMAB | 101576467 |
| 20203031 | 20153507 | 1.7 | 71.8 | Palliative (P) | 2019-01-06 | 2019-01-08 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101006154 |
| 20203073 | 20153508 | 1.54 | 70.8 | Adjuvant (A) | 2017-08-17 | 2017-08-19 | CETUXIMAB | 02 | N | CETUXIMAB | 100107024 |
| 20203075 | 20153509 | 1.72 | 70.5 | null | 2018-06-17 | 2018-06-17 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101441223 |
| 20203076 | 20153510 | 1.74 | 111.5 | Neo-adjuvant (N) | 2018-07-31 | 2018-08-14 | Trastuzumab | 02 | null | TRASTUZUMAB | 100235945 |
| 20203081 | 20153511 | 1.63 | 75 | Palliative (P) | 2016-04-30 | 2016-12-21 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100419605 |
| 20203096 | 20153512 | 0 | 41 | 02 | 2019-03-04 | 2019-05-31 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100662275 |
| 20203114 | 20153513 | 1.73 | 75.3 | Palliative (P) | 2020-05-05 | 2020-05-26 | CETUXIMAB | 02 | N | CETUXIMAB | 101062059 |